Showing results (1111-1120 of 1,161) with videos related to
Sort By:
Pageof 117
ACS Chemical Neuroscience|March 5, 2016
Design and Synthesis of New Transient Receptor Potential Vanilloid Type-1 (TRPV1) Channel Modulators: Identification, Molecular Modeling Analysis, and Pharmacological Characterization of the N-(4-Hydroxy-3-methoxybenzyl)-4-(thiophen-2-yl)butanamide, a Small Molecule Endowed with Agonist TRPV1 Activity and Protective Effects against Oxidative StressFrancesca Aiello, Mariateresa Badolato, Federica Pessina, et al.Chemmedchem|March 3, 2012
Investigations on the 4-quinolone-3-carboxylic acid motif part 5: modulation of the physicochemical profile of a set of potent and selective cannabinoid-2 receptor ligands through a bioisosteric approachClaudia Mugnaini, Stefania Nocerino, Valentina Pedani, et al.Annals of Intensive Care|November 26, 2021
Higher levels of IgA and IgG at sepsis onset are associated with higher mortality: results from the Albumin Italian Outcome Sepsis (ALBIOS) trialLaura Alagna, Jennifer M T A Meessen, Giacomo Bellani, et al.Pharmacological Research|December 7, 2020
Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed ratsMartina Di Bartolomeo, Tibor Stark, Oriana Maria Maurel, et al.Neuropharmacology|March 24, 2018
N-Oleoyl-glycine reduces nicotine reward and withdrawal in miceGiulia Donvito, Fabiana Piscitelli, Pretal Muldoon, et al.Marine Drugs|November 8, 2018
Fishing for Targets of Alien Metabolites: A Novel Peroxisome Proliferator-Activated Receptor (PPAR) Agonist from a Marine PestRosa Maria Vitale, Enrico D'Aniello, Stefania Gorbi, et al.Journal of Medicinal Chemistry|May 16, 2023
In Silico-Guided Rational Drug Design and Synthesis of Novel 4-(Thiophen-2-yl)butanamides as Potent and Selective TRPV1 AgonistsIsabella Romeo, Antonella Brizzi, Federica Pessina, et al.Molecular Psychiatry|November 19, 2019
Life-long epigenetic programming of cortical architecture by maternal 'Western' diet during pregnancyValentina Cinquina, Daniela Calvigioni, Matthias Farlik, et al.Neuropharmacology|December 14, 2024
Acute kappa opioid receptor blocking disrupts the pro-cognitive effect of cannabidiol in neuropathic ratsSerena Boccella, Antimo Fusco, Federica Ricciardi, et al.Neuropharmacology|November 30, 2018
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophreniaTibor Stark, Jana Ruda-Kucerova, Fabio Arturo Iannotti, et al.Pageof 117